C.A. Papadimitriou

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer

Flora Zagouri, Zsuzsanna Bagó-Horváth, Fabian Rössler et al. · British Journal of Cancer · 2013 · 97 citations · Full text

Medicine, Cancer Biology, Oncology +17

Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter Study

Meletios Α. Dimopoulos, C.A. Papadimitriou, Vassilis Georgoulias et al. · Gynecologic Oncology · 2000 · 86 citations

Medicine, Gynecology, Oncology +15

Recombinant human stem cell factor does exert minor stimulation of growth in small cell lung cancer and melanoma cell lines

C.A. Papadimitriou, Max S. Topp, Hubert Serve et al. · European Journal of Cancer · 1995 · 31 citations

Life Sciences, Cell Biology, Oncology +11

Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study

Giannis Mountzios, Meletios Α. Dimopoulos, Aristotelis Bamias et al. · Annals of Oncology · 2009 · 28 citations · Full text

Medicine, Oncology, Pharmacology +11

Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapy.

M Koenigsmann, Michael Notter, Wolfgang Knauf et al. · PubMed · 1996 · 24 citations

Medicine, Hematology, Oncology +16